Advanced

Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer : A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium

Van Dorp, Wendy; Mulder, Renée L.; Kremer, Leontien C M; Hudson, Melissa M.; Van Den Heuvel-Eibrink, Marry M.; Van Den Berg, Marleen H.; Levine, Jennifer M.; Van Dulmen-Den Broeder, Eline; Di Iorgi, Natascia and Albanese, Assunta, et al. (2016) In Journal of Clinical Oncology 34(28). p.3440-3450
Abstract

Purpose: Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treated with alkylating agents and/or radiation, with potential exposure of the ovaries, have an increased risk of premature ovarian insufficiency (POI). Clinical practice guidelines can facilitate these survivors' access to optimal treatment of late effects that may improve health and quality of survival; however, surveillance recommendations vary among the existing long-term follow-up guidelines, which impedes the implementation of screening. Patients and Methods: The present guideline was developed by using an evidence-based approach and summarizes harmonized POI surveillance recommendations for female survivors of CAYA cancer who were... (More)

Purpose: Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treated with alkylating agents and/or radiation, with potential exposure of the ovaries, have an increased risk of premature ovarian insufficiency (POI). Clinical practice guidelines can facilitate these survivors' access to optimal treatment of late effects that may improve health and quality of survival; however, surveillance recommendations vary among the existing long-term follow-up guidelines, which impedes the implementation of screening. Patients and Methods: The present guideline was developed by using an evidence-based approach and summarizes harmonized POI surveillance recommendations for female survivors of CAYA cancer who were diagnosed at age < 25 years. The recommendations were formulated by an international multidisciplinary panel and graded according to the strength of the evidence and the potential benefit gained from early detection and intervention. The harmonized POI surveillance recommendations were developed by using a transparent process and are intended to facilitate care for survivors of CAYA cancer. Results and Conclusion: The harmonized set of POI surveillance recommendations is intended to be scientifically rigorous, to positively influence health outcomes, and to facilitate the care for female survivors of CAYA cancer.

(Less)
Please use this url to cite or link to this publication:
@article{4b1e287d-ea68-44a1-8b35-dd8da252279a,
  abstract     = {<p>Purpose: Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were treated with alkylating agents and/or radiation, with potential exposure of the ovaries, have an increased risk of premature ovarian insufficiency (POI). Clinical practice guidelines can facilitate these survivors' access to optimal treatment of late effects that may improve health and quality of survival; however, surveillance recommendations vary among the existing long-term follow-up guidelines, which impedes the implementation of screening. Patients and Methods: The present guideline was developed by using an evidence-based approach and summarizes harmonized POI surveillance recommendations for female survivors of CAYA cancer who were diagnosed at age &lt; 25 years. The recommendations were formulated by an international multidisciplinary panel and graded according to the strength of the evidence and the potential benefit gained from early detection and intervention. The harmonized POI surveillance recommendations were developed by using a transparent process and are intended to facilitate care for survivors of CAYA cancer. Results and Conclusion: The harmonized set of POI surveillance recommendations is intended to be scientifically rigorous, to positively influence health outcomes, and to facilitate the care for female survivors of CAYA cancer.</p>},
  author       = {Van Dorp, Wendy and Mulder, Renée L. and Kremer, Leontien C M and Hudson, Melissa M. and Van Den Heuvel-Eibrink, Marry M. and Van Den Berg, Marleen H. and Levine, Jennifer M. and Van Dulmen-Den Broeder, Eline and Di Iorgi, Natascia and Albanese, Assunta and Armenian, Saro H. and Bhatia, Smita and Constine, Louis S. and Corrias, Andreas and Deans, Rebecca and Dirksen, Uta and Gracia, Clarisa R. and Hjorth, Lars and Kroon, Leah and Lambalk, Cornelis B. and Landier, Wendy and Levitt, Gill and Leiper, Alison and Meacham, Lillian and Mussa, Alesandro and Neggers, Sebastian J. and Oeffinger, Kevin C. and Revelli, Alberto and Van Santen, Hanneke M. and Skinner, Roderick and Toogood, Andrew and Wallace, William H. and Haupt, Riccardo},
  issn         = {0732-183X},
  language     = {eng},
  month        = {10},
  number       = {28},
  pages        = {3440--3450},
  publisher    = {American Society of Clinical Oncology},
  series       = {Journal of Clinical Oncology},
  title        = {Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer : A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium},
  url          = {http://dx.doi.org/10.1200/JCO.2015.64.3288},
  volume       = {34},
  year         = {2016},
}